Please check your internet connection and try again.
# Clobazam (Oral Formulation)
## Overview
Clobazam is a benzodiazepine derivative with anticonvulsant properties. It acts as a positive allosteric modulator of the GABA-A receptor, enhancing inhibitory neurotransmission.
## Primary Indications
* Adjunctive therapy for Lennox-Gastaut syndrome (LGS) in patients 2 years and older.
* Adjunctive therapy for other seizure types (e.g., partial seizures, absence seizures) where oral therapy is suitable.
## Adult Dosing
**Lennox-Gastaut Syndrome:**
* **Initiation:** 5 mg twice daily.
* **Maintenance:** Titrate dose by 5-10 mg/day every week based on clinical response and tolerability, to a maximum of 20 mg twice daily (40 mg/day).
**Other Seizure Types:**
* Dosing varies depending on the seizure type and patient response. Consult specific guidelines or prescribing information. A typical starting dose may be 5 mg once or twice daily, with titration up to a maximum of 30 mg twice daily (60 mg/day) or as indicated by clinical response.
## Pediatric Dosing
**Lennox-Gastaut Syndrome (2 years and older):**
* **Initiation:** 5 mg twice daily.
* **Maintenance:** Titrate dose by 5-10 mg/day every week based on clinical response and tolerability, to a maximum of 10 mg twice daily (20 mg/day) for patients weighing less than 30 kg, and 20 mg twice daily (40 mg/day) for patients weighing 30 kg or more.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; consider lower starting doses and slower titration.
* **Geriatric Patients:** Use with caution; consider lower starting doses and slower titration due to increased sensitivity to CNS effects.
## Contraindications
* Known hypersensitivity to clobazam or other benzodiazepines.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Acute narrow-angle glaucoma.
## Adverse Effects
Common adverse effects include somnolence, decreased appetite, constipation, aggression, irritability, and ataxia. Serious adverse effects include severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis), suicidal behavior or ideation, and respiratory depression.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, other sedatives):** Additive CNS depression may occur. Use caution and consider dose reduction of one or both agents.
* **CYP3A4 Inhibitors/Inducers:** Clobazam is metabolized by CYP3A4. Inhibitors may increase clobazam levels, while inducers may decrease them.
* **Other Anticonvulsants:** Monitor for changes in efficacy or toxicity.
## Monitoring
* Seizure frequency and type.
* Signs and symptoms of CNS depression.
* Signs of withdrawal upon discontinuation.
* Suicidal behavior or ideation.
* Severe skin reactions.
## Clinical Pearls
* Clobazam has a relatively long half-life, allowing for once or twice daily dosing.
* Tapering of the dose is necessary upon discontinuation to avoid withdrawal symptoms.
* Caution is advised when used in combination with opioids due to the risk of profound sedation, respiratory depression, coma, and death.
---
***Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and guidelines for definitive patient management.*
